Science Explorer Back to mapMap
Discussion

Adare Pharma Solutions (United States)

Research works
5
▲ 67% vs 2018-21
Citations
25
5.1 per fractional work
Top-10% rate
5.0%
all institutions 10.0%
Open access
14%
world 40%
International
19%
world 18%
Adare Pharma Solutions (United States)

Not ranked overall: Adare Pharma Solutions (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Adare Pharma Solutions (United States) work in?

In all years, 48% of research at Adare Pharma Solutions (United States) is in Physical Sciences, 33% in Health Sciences. Its largest fields are Medicine (33%), Chemistry (21%), Materials Science (21%).

Life Sciences19%Physical Sciences48%Health Sciences33%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 8 fields, with their numbers
    1. Chemistry120.8%
    2. Materials Science120.8%
    3. Engineering06.2%
    1. Medicine233.3%
    1. Biochemistry, Genetics and Molecular Biology06.2%
    2. Pharmacology, Toxicology and Pharmaceutics06.2%
    3. Neuroscience04.2%
    4. Agricultural and Biological Sciences02.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.84× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.25× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 34.05× its world share, 0 worksPharmacology, Toxico…Chemistry: 15.29× its world share, 1 worksChemistryEngineering: 0.62× its world share, 0 worksEngineeringMaterials Science: 3.44× its world share, 0 worksMaterials ScienceMedicine: 1.25× its world share, 1 worksMedicineEconomics, Econometrics and Finance: 0.62× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.11× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 34.0×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics34.05×0 works
  2. Chemistry15.29×1 works
  3. Materials Science3.44×0 works
  4. Biochemistry, Genetics and Molecular Biology2.25×0 works
  5. Medicine1.25×1 works
  6. Agricultural and Biological Sciences0.84×0 works
  7. Engineering0.62×0 works
  8. Economics, Econometrics and Finance0.62×0 works
  9. Social Sciences0.11×0 works

What are the most cited papers from Adare Pharma Solutions (United States)?

The most cited paper from Adare Pharma Solutions (United States) is "Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis" (Ikuo Hirano, Ekaterina Safroneeva, Marie Roumet et al., 2020), with 44 citations. Next come "Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis" (30) and "EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study" (18).

Most cited papers
#PaperReleasedCitations
1 Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis Ikuo Hirano, Ekaterina Safroneeva, Marie Roumet et al. · Alimentary Pharmacology & Therapeutics 9 Mar 2020 44
2 Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis Alain M. Schoepfer et al. · Clinical Gastroenterology and Hepatology 23 Nov 2018 30
3 EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study Michael S. Berlin, Cheryl L. Rowe-Rendleman, Iqbal Ike K. Ahmed et al. · British Journal of Ophthalmology Open access 9 Oct 2015 18
4 Brain translocator protein occupancy by ONO‐2952 in healthy adults: A Phase 1 PET study using [11C]PBR28 William Gordon Frankle, Rajesh Narendran, Andrew Wood et al. · Synapse Mar 2017 8
5 Effect of Food Intake and Body Position on the Pharmacokinetics of Swallowed APT‐1011, a Fluticasone Orally Disintegrating Tablet, in Healthy Adult Volunteers Gail M. Comer, Mark Bush, Evan S. Dellon et al. · The Journal of Clinical Pharmacology 15 Jan 2020 6
All 7 most cited papers, with filters and sorting

Which research topics does Adare Pharma Solutions (United States) publish most on?

By volume in 2022-now: Synthesis and Properties of Aromatic Compounds, Pharmacogenetics and Drug Metabolism, Microbial Natural Products and Biosynthesis and Fullerene Chemistry and Applications.

  1. 1 Synthesis and Properties of Aromatic Compounds Organic Chemistry 0 works
  2. 2 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  3. 3 Microbial Natural Products and Biosynthesis Pharmacology 0 works
  4. 4 Fullerene Chemistry and Applications Organic Chemistry 0 works
  5. 5 Enzyme Catalysis and Immobilization Molecular Biology 0 works
  6. 6 Carbon Nanotubes in Composites Materials Chemistry 0 works
  7. 7 Electrohydrodynamics and Fluid Dynamics Electrical and Electronic Engineering 0 works
  8. 8 Pregnancy and Medication Impact Public Health, Environmental and Occupational Health 0 works
  9. 9 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
  10. 10 Reproductive Health and Contraception Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available13.6%not open86.4%

World: 40% of research is openly available.

with international co-authors18.6%domestic only81.4%

World: 18% is written across borders.

How has Adare Pharma Solutions (United States)'s research output changed?

Output in 2022-2025 was 67% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lawrenceville

All research institutions in Lawrenceville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Adare Pharma Solutions (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.